Select Medical Holdings Corporation SEM
Set alert
16.51 USD 0.00 0.00%
At close · Jun 30
16.53 +0.02 +0.12%
After hours · Jun 30, 4:02 PM ET
16.51 Day range 16.56
12.61 52-week range 16.99
- YTD
- +11.18%
- 1 year
- +9.99%
- Open
- 16.52
- Prev close
- 16.51
- Mkt cap
- 2.05B
- Vol
- 14.27M
- Avg vol
- 3.48M
- EPS
- 1.06
- P/E
- 13.08
- Div yield
- 1.51%
More statistics
- Low
- 16.51
- High
- 16.56
- Beta
- 0.79
- Inst. own
- 82.48%
- Dividend
- 0.25
- Earnings
- Jul 30, 2026
Analyst view
Price target (mean) —
Ratings (0m) 4 0 buy · 4 hold · 0 sell
- Strong buy0
- Buy0
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.29816 | 0.26921 – 0.34 | 0.32 | -6.8% | 1.40B | +4.5% | 5 |
| Next quarter | 0.23792 | 0.18575 – 0.28 | 0.23 | +3.4% | 1.42B | +4.1% | 5 |
| Current year | 1.22 | 1.11 – 1.30 | 1.16 | +5.6% | 5.70B | +4.6% | 5 |
| Next year | 1.38 | 1.26 – 1.50 | 1.22 | +13.0% | 5.97B | +4.7% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 13, 2026 | Mizuho | Downgrade | Outperform | Neutral |
| Mar 4, 2026 | Benchmark | Downgrade | Buy | Hold |
| Mar 3, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Feb 23, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 4, 2025 | UBS | Maintained | Neutral | Neutral |
| May 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 24, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 3, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 25, 2024 | Benchmark | Downgrade | Buy | Hold |
| Nov 4, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 4, 2024 | Benchmark | Reiterated | Buy | Buy |
| Nov 1, 2024 | Benchmark | Reiterated | Buy | Buy |
| Sep 6, 2024 | Benchmark | Reiterated | Buy | Buy |
| Aug 5, 2024 | Benchmark | Reiterated | Buy | Buy |
| Aug 2, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jul 16, 2024 | Benchmark | Maintained | Buy | Buy |
| May 6, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2024 | Benchmark | Maintained | Buy | Buy |
| May 3, 2024 | Benchmark | Reiterated | Buy | Buy |
| Apr 12, 2024 | Benchmark | Reiterated | Buy | Buy |
| Nov 30, 2023 | UBS | Initiated | — | Neutral |
| Nov 8, 2023 | Benchmark | Reiterated | Buy | Buy |
| Aug 7, 2023 | Credit Suisse | Maintained | Neutral | Neutral |
| Jul 20, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| May 8, 2023 | RBC Capital | Maintained | — | Outperform |
| May 8, 2023 | Credit Suisse | Reiterated | — | Neutral |
| Feb 27, 2023 | Benchmark | Reiterated | — | Buy |
| Feb 27, 2023 | Credit Suisse | Maintained | — | Neutral |
